Nyhetsbyrån Direkt invited Neola Medical’s CEO Hanna Sjöström during her participation at the Stanford Impact1 CEO Summit conference in Palo Alto, USA, to hear more about the importance of the Stanford Impact1 support ahead of the U.S. launch of the company’s medical device product Neola®, for continuous lung monitoring of the lungs of preterm born babies. See more in the interview below.